Bibliography
Wiltschke, C., Wiedermann, U., Zurbriggen, R., Elandt, K., Brämswig, K., Jasinska, J., Pehamberger, H., Scheiner, O., & Zielinski, C. C. (2008). A phase I study to evaluate safety, immunogenicity and antitumor activity of a HER2 multi-peptide virosome vaccine in patients with metastatic breast cancer. Journal of Clinical Oncology, 26(15_suppl), 3055â3055.
Dates
Type | When |
---|---|
Created | 8 years, 6 months ago (Feb. 24, 2017, 2:33 a.m.) |
Deposited | 5 years, 9 months ago (Nov. 27, 2019, 4:27 p.m.) |
Indexed | 3 years, 4 months ago (March 30, 2022, 12:42 p.m.) |
Issued | 17 years, 3 months ago (May 20, 2008) |
Published | 17 years, 3 months ago (May 20, 2008) |
Published Print | 17 years, 3 months ago (May 20, 2008) |
@article{Wiltschke_2008, title={A phase I study to evaluate safety, immunogenicity and antitumor activity of a HER2 multi-peptide virosome vaccine in patients with metastatic breast cancer}, volume={26}, ISSN={1527-7755}, url={http://dx.doi.org/10.1200/jco.2008.26.15_suppl.3055}, DOI={10.1200/jco.2008.26.15_suppl.3055}, number={15_suppl}, journal={Journal of Clinical Oncology}, publisher={American Society of Clinical Oncology (ASCO)}, author={Wiltschke, C. and Wiedermann, U. and Zurbriggen, R. and Elandt, K. and Brämswig, K. and Jasinska, J. and Pehamberger, H. and Scheiner, O. and Zielinski, C. C.}, year={2008}, month=may, pages={3055–3055} }